August 31, 2016: Novartis is dissolving its high-profile cell and gene therapy unit operating under the guiding hand of Usman “Oz” Azam, Endpoints has learned. Azam has issued a note to the 400 staffers in the group.
August 31, 2016: Embattled Theranos has run into another testing snag. This time with its proposed blood test for the Zika virus. The company was forced to withdraw its request for emergency clearance of the test.
August 31, 2016: Teva, headquartered in Israel, is expected to lay off 80 people at its Haverstraw, New York facility. The manufacturing plant currently employs 236 people and focuses on the manufacture of niacin.
August 31, 2016: The dog days of summer aren't the usual time for anticipating a wave of corporate activity, but that's exactly what has been happening in August.